Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer
Research Abstract
NULL
Research Department
Research Journal
Kasr Al-Aini J. of Clinical Oncology and Nuclear Medicine
Research Member
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015
Do you have any questions?